IDO1 expression in tumor cell lines and primary tumor cells is mainly triggered by IFN-γ and translates into tryptophan degradation into immune suppressive metabolites, collectively referred to as kynurenines [73]. The gene discussed is IFNG; the disease is neoplasm.